Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

Completed · Phase 1

Conditions studied: Invasive Candidiasis

In brief

Determine proper dosing of micafungin in children supported with extracorporeal membrane oxygenation (ECMO).

Key facts

Study ID

NCT01666769

Run by

Kevin Watt

People needed

18

Starts

2013-01-01

Expected to finish

2016-02-09

Last updated by the study team

2019-11-05

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• <= 17.85 years at the time of enrollment.
• Sufficient venous access to permit administration of study medication.
• Supported with either venoarterial (VA) or venovenous (VV) ECMO.
• Availability and willingness of the parent/legal guardian to provide written informed consent.
• For treatment dosing arm: confirmed or suspected infection

You may not qualify if…

• Subject with a history of anaphylaxis attributed to an echinocandin.
• Any other concomitant condition, which in the opinion of the investigator would preclude a subject's participation in the study.
• Previous participation in this study.
• Pregnancy

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.